Evidence map›Paper›PMID 27385056›Full record

ArticleAdvanced healthcare materials2016

Amorphous Silica: A New Antioxidant Role for Rapid Critical-Sized Bone Defect Healing.

Azhar Ilyas, Tetsuro Odatsu, Ami Shah, Felipe Monte, Harry K W Kim, Philip Kramer, Pranesh B Aswath, Venu G Varanasi

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. SiONAntioxidants (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Azhar IlyasDepartment of Biomedical Sciences, Texas A&M University, Baylor College of Dentistry, Dallas, TX, 75246, USA.
Tetsuro OdatsuDepartment of Biomedical Sciences, Texas A&M University, Baylor College of Dentistry, Dallas, TX, 75246, USA.
Ami ShahDepartment of Materials Science and Engineering, University of Texas at Arlington, Arlington, TX, 76019, USA.
Felipe MonteDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, 76019, USA.
Harry K W KimCenter for Excellence in Hip Disorders, Texas Scottish Rite Hospital, Dallas, TX, 75219, USA.
Philip KramerDepartment of Biomedical Sciences, Texas A&M University, Baylor College of Dentistry, Dallas, TX, 75246, USA.
Pranesh B AswathDepartment of Materials Science and Engineering, University of Texas at Arlington, Arlington, TX, 76019, USA.
Venu G VaranasiDepartment of Biomedical Sciences, Texas A&M University, Baylor College of Dentistry, Dallas, TX, 75246, USA. varanasi@bcd.tamhsc.edu.
Texas A&M University · USThe University of Texas at Arlington · USBaylor University · USScottish Rite Hospital · US

Funding

Silicon, a Novel Antioxidant Role in Bone HealingR03DE023872 · NIDCR · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI VARANASI, VENU GOPAL · 2014 to 2015
$229k
CIHRNIDCR NIH HHS R03 DE023872
6 · The paper itself

Abstract

Traumatic fractures cause structurally unstable sites due to severe bone loss. Such fractures generate a high yield of reactive oxygen species (ROS) that can lead to oxidative stress. Excessive and prolonged ROS activity impedes osteoblast differentiation and instigates long healing times. Stimulation of antioxidants such as superoxide dismutase (SOD1), are crucial to reduce ROS, stimulate osteogenesis, and strengthen collagen and mineral formation. Yet, no current fixative devices have shown an ability to enhance collagen matrix formation through antioxidant expression. This study reports plasma-enhanced chemical vapor deposition based amorphous silicon oxynitride (Si(ON)x) as a potential new fracture healing biomaterial that adheres well to the implant surface, releases Si(+4) to enhance osteogenesis, and forms a surface hydroxyapatite for collagen mineral attachment. These materials provide a sustained release of Si(+4) in physiological environment for extended times. The dissolution rate partially depends on the film chemistry and can be controlled by varying O/N ratio. The presence of Si(+4) enhances SOD1, which stimulates other osteogenic markers downstream and leads to rapid mineral formation. In vivo testing using a rat critical-sized calvarial defect model shows a more rapid bone-regeneration for these biomaterials as compared to control groups, that implies the clinical significance of the presented biomaterial.

Indexed as

Fracture HealingSilicon DioxideAnimalsCell LineFractures, BoneMaleMiceRatsReactive Oxygen SpeciesSuperoxide Dismutase-1Reactive Oxygen SpeciesSilicon DioxideSod1 protein, mouseSod1 protein, ratSuperoxide Dismutase-1antioxidantsblood vessel formationbone formationPECVDsuperoxide dismutase

Identifiers

PMID27385056
PMCPMC6635139
OpenAlexW2463100003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.